Pyrimethamine regulates m6A modification of CCND1 via METTL14/YTHDF2 to inhibit hepatocellular carcinoma
Fields of Study & Subjects
RNA modifications and cancer
Ubiquitin and proteasome pathways
Protein Degradation and Inhibitors
Publication details
- Journal / source
- Bioorganic Chemistry
- Publisher
- Elsevier BV
- Volume
- 176
- Pages
- 109892–109892
- Publication date
- 17 April 2026
- Language
- EN